James Moon

Also affiliated with Harvard University, Barts Health NHS Trust, University of Michigan, Massachusetts General Hospital, Gene Therapy Laboratory, BioSurfaces (United States), University College London

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 35 papers. Top paper: “Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma”.

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

New England Journal of Medicine(2023)10.1056/nejmoa2211437

N/A

6.5DataRank · unranked

846 citations

Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom +48 more

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02498-y

N/A

4.8DataRank · unranked

171 citations

Shay Bellasea, Kari Kendra, Nikhil I. Khushalani, Katie M. Campbell, Philip O. Scumpia +28 more

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

The Lancet(2017)10.1016/s0140-6736(17)32129-3

N/A

1.3DataRank · unranked

7558 citations

Ziad A Abdeen, Zargar Abdul Hamid, Niveen M Abu-Rmeileh, Benjamin Acosta-Cazares, Cecilia Acuin +1262 more

Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9501

N/A

1.3DataRank · unranked

18 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Teresa M. Petrella +15 more

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

The Lancet Oncology(2020)10.1016/s1470-2045(20)30475-7

N/A

0.725DataRank · unranked

125 citations

Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +21 more

EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.10.002

N/A

0.659DataRank · unranked

13 citations

Mary W. Redman, James Moon, Francesco Agustoni, Roy S. Herbst, Thomas J. Semrad +6 more

A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers

Cancer(2024)10.1002/cncr.35200

N/A

0.612DataRank · unranked

12 citations

James Moon, Christopher D. Lao, Bartosz Chmielowski, Kari Kendra, Karl D. Lewis +12 more

Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI–Treated Patients with EGFR -Mutant NSCLC (SWOG S1403)

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0741

N/A

0.606DataRank · unranked

56 citations

Jieling Miao, Mary W. Redman, James Moon, Sarah B. Goldberg, Roy S. Herbst +7 more

Landmark Detection in Cardiac MRI by Using a Convolutional Neural Network

Radiology Artificial Intelligence(2021)10.1148/ryai.2021200197

N/A

0.604DataRank · unranked

55 citations

Jessica Artico, Marianna Fontana, James Moon, Rhodri Davies, Peter Kellman +1 more

Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR

JACC. Cardiovascular imaging(2021)10.1016/j.jcmg.2021.03.029

N/A

0.574DataRank · unranked

45 citations

Kristopher Knott, Katia Menacho, João B. Augusto, Rhodri Davies, Iain Pierce +12 more

H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts

Clinical Epigenetics(2020)10.1186/s13148-020-00895-5

N/A

0.553DataRank · unranked

39 citations

Magdaléna Harakaľová, Thomas A. Treibel, R Thomas Lumbers, Bastiaan J. Boukens, Igor R. Efimov +22 more

Residual circulating tumor DNA (ctDNA) after two months of therapy to predict progression-free and overall survival in patients treated on S1403 with afatinib +/- cetuximab.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9532

N/A

0.552DataRank · unranked

9 citations

Mary W. Redman, James Moon, Sarah B. Goldberg, Roy S. Herbst, Mary Ann Melnick +6 more

Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma

Cancer(2024)10.1002/cncr.35587

N/A

0.539DataRank · unranked

9 citations

James Moon, T. Vincent, John P. Fruehauf, Lawrence E. Flaherty, Martin J. Bury +8 more

Neoadjuvant PD-1 blockade in patients with resectable desmoplastic melanoma (SWOG 1512).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9502

N/A

0.464DataRank · unranked

21 citations

James Moon, Zeynep Eroglu, Siwen Hu‐Lieskovan, William E. Carson, David A. Wada +15 more

S1801: A randomized trial of adjuvant versus neoadjuvant pembrolizumab for melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps9585

N/A

0.208DataRank · unranked

3 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +9 more

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.08.515436

N/A

0.208DataRank · unranked

3 citations

Yanchun Peng, Cedric Tan, Michal Mark, Gayathri Nageswaran, Suzanne Byrne +31 more

Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade adjuvant therapy: An analysis of 1670 high-risk patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9582

N/A

0.104DataRank · unranked

1 citations

Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood +5 more

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner

Cell Host & Microbe(2021)10.1016/j.chom.2021.10.003

N/A

0DataRank · unranked

117 citations

Simone I. Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B. Tincho, Ntombi Benede +30 more

Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning

Journal of Cardiovascular Magnetic Resonance(2022)10.1186/s12968-022-00846-4

N/A

0DataRank · unranked

90 citations

João B. Augusto, Anish Bhuva, Hui Xue, Thomas A. Treibel, Yang Ye +19 more

Association of prior immune checkpoint blockade (ICB) with longer progression-free survival (PFS) in patients treated with intermittent versus continuous dabrafenib and trametinib: A post-hoc analysis of S1320.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10039

N/A

0DataRank · unranked

1 citations

Megan Othus, Adil Daud, Janice M. Mehnert, Thach‐Giao Truong, Robert M. Conry +15 more

Quantitative Myocardial Perfusion Predicts Outcomes in Patients With Prior Surgical Revascularization

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2021.12.037

N/A

0DataRank · unranked

29 citations

Benjamin Dowsing, Krishnaraj S. Rathod, Hunain Shiwani, Kush Patel, Kristopher Knott +14 more

An accurate and time-efficient deep learning-based system for automated segmentation and reporting of cardiac magnetic resonance-detected ischemic scar

Computer Methods and Programs in Biomedicine(2022)10.1016/j.cmpb.2022.107321

N/A

0DataRank · unranked

22 citations

Kirsten C. J. van Abeelen, Rhodri Davies, Roberto Menè, Francesca Heilbron, Francesco Perelli +11 more

S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10090

N/A

0DataRank · unranked

1 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +8 more

Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis

Journal of the American College of Cardiology(2025)10.1016/j.jacc.2024.10.082

N/A

0DataRank · unranked

43 citations

Rhodri Davies, Constantin‐Cristian Topriceanu, Raffaello Ditaranto, Anjali Owens, Betty Raman +56 more

IRF8 Governs Tumor-Associated Macrophage Control of T Cell Exhaustion

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.12.989731

N/A

0DataRank · unranked

4 citations

Fengshen Kuo, Ming Liu, Kristelle J. Capistrano, Mytrang Do, Ruth A. Franklin +15 more

Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation

UNC Libraries(2020)10.17615/sfd3-pt41

N/A

0DataRank · unranked

4 citations

Roshi Afshar, Morris Ling, Ramnik J. Xavier, James Moon, Daniel L. Hamilos +16 more

Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy

Circulation Cardiovascular Imaging(2023)10.1161/circimaging.122.014907

N/A

0DataRank · unranked

44 citations

João B. Augusto, Kristopher Knott, Rhodri Davies, Hunain Shiwani, Andreas Seraphim +13 more

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection

iScience(2023)10.1016/j.isci.2023.106937

N/A

0DataRank · unranked

19 citations

Yanchun Peng, Cedric Tan, Michal Mark, Gayathri Nageswaran, Suzanne Byrne +30 more

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Cancers(2023)10.3390/cancers15092561

N/A

0DataRank · unranked

13 citations

Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus +7 more

A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps9603

N/A

0DataRank · unranked

7 citations

James Moon, Yana G. Najjar, Rupesh Kotecha, Vadim Spektor, Michael C. Wu +6 more

Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

(2023)10.1158/2159-8290.c.6549583.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Quantitative cardiovascular magnetic resonance myocardial perfusion mapping to assess hyperaemic response to adenosine stress

European Heart Journal - Cardiovascular Imaging(2020)10.1093/ehjci/jeaa252

N/A

0DataRank · unranked

25 citations

Juan Manuel Monteagudo Ruiz, Ana Martinez–Naharro, Liza Chacko, James Brown, Daniel Knight +11 more

Automated detection of left ventricle in arterial input function images for inline perfusion mapping using deep learning: A study of 15,000 patients

Magnetic Resonance in Medicine(2020)10.1002/mrm.28291

N/A

0DataRank · unranked

29 citations

Ethan Tseng, Kristopher Knott, Tushar Kotecha, Louise Brown, Sven Plein +4 more

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner

medRxiv(2021)10.1101/2021.07.24.21261037

N/A

0DataRank · unranked

14 citations

Simone I. Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B. Tincho, Ntombi Benede +30 more

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1141

N/A

0DataRank · unranked

102 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more